Generation, validation, and large scale production of adenoviral recombinants with large size inserts such as a 6.3 kb human dystrophin cDNA

Journal of Virological Methods

Volumn 64, Issue 2, 1997, Pages 111-124

  Jani, Agnes ^a,c   Lochmüller, Hanns ^a   Acsadi, Gyula ^a,c   Simoneau, Maude ^b   Huard, Johnny ^a   Garnier, Alain ^b   Karpati, George ^a   Massie, Bernard ^b  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adenoviral recombinant; dystrophin; gene therapy

Indexed keywords

COMPLEMENTARY DNA; DYSTROPHIN; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; GENE THERAPY; GENE TRANSFER; HUMAN; MOLECULAR CLONING; PRIORITY JOURNAL; PROMOTER REGION; VIRUS RECOMBINANT;

ADENOVIRUSES, HUMAN; ANIMALS; CELL LINE, TRANSFORMED; DNA, COMPLEMENTARY; DYSTROPHIN; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED MDX; MUTAGENESIS, INSERTIONAL; RECOMBINATION, GENETIC;

ADENOVIRIDAE; CUCUMBER MOSAIC VIRUS; RICE STRIPE VIRUS;

EID: 19244371603     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(96)02138-6     Document Type: Article

References (51)

1. Acsadi, G., Dickson, G., Love, D., Jani, A., Gurusinghe, A., Walsh, F.S., Wolff, J.A. and Davies K.E. (1991) Human dystrophin expression in mdx mice after injection of DNA constructs. Nature 352, 815-818.
2. Acsadi. G., Jani, A., Massie, B., Simoneau, M., Holland, P., Blaschuk, K. and Karpati, G. (1994) A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet. 3, 579-584.
3. Acsadi, G., Lochmüller, H., Jani, A., Huard, J., Massie, B., Prescott, S., Simoneau, M., Petrof, B.J. and Karpati, G. (1996) Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum. Gene Ther. 7, 129-140.
4. Acsadi, G., Massie, B. and Jani, A. (1995). Adenovirus-mediated gene transfer into striated muscles. J. Mol. Med. 73, 165-180.
5. Berkner, K.L. (1988). Development of adenovirus vectors for the expression of heterologous genes. BioTechniques 6, 616-629.
6. Berkner, K.L. (1992). Expression of heterologous sequences in adenoviral vectors. Curr. Top. Microbiol. Immunol. 158, 39-66.
7. Berkner, K.L., Schaffhausen, G.S., Roberts, T.M. and Sharp, P.A. (1987). Abundant expression of polyomavirus middle T antigen and dihydrofolate reductase in an adenovirus recombinant. J. Virol. 61, 1213-1220.
8. Berkner, K.L. and Sharp, P. (1983) Generation of adenovirus by transfection of plasmids. Nucleic Acid Res. 11, 6003-6020.
9. Bett, A.J., Haddara, W., Prevec, L. and Graham, F.L. (1994) An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91, 8802-8806.
10. Bett, A.J., Prevec, L. and Graham, F.L. (1993) Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol. 67, 5911-5921.
11. Boucher, R.C. and Knowles, M.R. (1994) Gene therapy for cystic fibrosis using E1-deleted adenovirus: A phase I trial in the nasal cavity. Hum. Gene Ther. 5, 615-639.
12. Caravokyri, C. and Leppard, K.N. (1995) Constitutive episomal expression of polypeptide IX (plx) in 293-based cell line complements the deficiency of plx mutant Adenovirus type 5. J. Virol. 69, 6627-6633.
13. Chroboczek, J., Bieber, F. and Jacrot, B. (1992) The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology 186, 280-285.
14. Clemens, P.R., Krause, T.L., Chan, S., Korb, K.E., Graham, F.L. and Caskey, C.T. (1995) Recombinant truncated dystrophin minigenes: construction, expression, and adenoviral delivery. Hum. Gene Ther. 6, 1477-1485.
15. Engelhardt, J., Yang, Y., Stratford-Perricaudet, L., Allen, E., Kozarsky, K., Perricaudet, M., Yankaskas, J. and Wilson, J. (1993) Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nature Genet. 4, 27-34.
16. England. S., Nicholson, L., Johnson, M., Forrest, S., Love, D., Zubrzyczka-Gaarn, E., Bulman, D., Harris, J. and Davies, K. (1990) Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 343, 180-182.
17. Garnier, A., Côté, J., Nadeau, I., Kamen, A. and Massie, B. (1994) Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells. Cytotechnology 15, 145-155.
18. Gerard, R.D. and Meidell, R.S. (1993) Adenovirus-mediated gene transfer. Trends Cardiovasc. Med. 5, 171-177.
19. Gil, A. and Proudfoot, N. (1987) Position-dependent sequence elements downstream of AAUAAA are required for efficient rabbit β-Globin mRNA 3′-end formation. Cell 49, 399-406.
20. Gluzman, Y., Reichl, H. and Solnick, D. 1982. Helper-free adenovirus type 5 vectors. In Y. Gluzman, (Ed.), Eucaryotic Viral Vectors. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. pp. 187-192.
21. Graham, F.L. and Prevec, L. (1991) In E.J. Murray (ed.). Gene Transfer and Expression Protocols. The Humana Press, Clifton, NJ, pp. 109-114.
22. Graham, F.L., Smiley, J.R., Russell, W.C. and Nairn, R. (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-72.
23. Gross-Bellard, M., Oudet P. and Chambon, P. (1972) Isolation of high-molecular-weight DNA from mammalian cells. Eur. J. Biochem. 36, 32.
24. Haj-Ahmad, Y. and Graham, F. (1986) Development of a helper-independent human adenovirus vector and its use in the transfer of the herpes simplex thymidine kinase gene. J. Virol. 57, 267-274.
25. Imler, J-L., Chartier, C., Dieterlé, A., Mehtali, M. and Pavriani, A. (1995) An efficient procedure to select and recover recombinant adenovirus vectors. Gene Ther. 2, 263-268.
26. Jordan, M., Schallhorn, A. and Wurm, F.L. (1996) Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate formation. Nucleic Acid Res. 24, 596-601.
27. Jordan, M. and Wurm, F.L. (1995) High level transient expression in mammalian cells: identification and optimization of physico-chemical parameters of the calcium phosphate method. In E.C. Beuvery et al. (eds), Animal Cell Technology: Developments towards the 21st Century. Butterworth-Heinemann, Oxford, pp. 49-55.
28. Kochanek, S., Clemens, P., Mitani, K., Chen, H.-H., Chan, S. and Caskey, T. (1996) A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc. Natl. Acad. Sci. USA 93, 5731-5736.
29. Koenig, M., Monaco, E., Bertelson, C., Monaco, A., Feener, C. and Kunkel, L. (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organisation of the DMD gene in normal and affected individuals. Cell 50, 509-517.
30. Lamarche, N., Massie, B., Richer, M., Paradis, H. and Langelier, Y. (1990) High level of expression in 293 cells of herpes simplex virus type 2 ribonucleotide reductase subunit 2 using an adenovirus vector. J. Gen. Virol. 71, 1785-1792.
31. Levitt, N., Briggs, D., Gil, A. and Proudfoot, N. (1989) Definition of an efficient synthetic poly(A) site. Genes Dev. 3, 1019-1025.
32. Lochmüller, H., Jani, A., Huard, J., Prescott, S., Simoneau, M., Massie, B., Karpati, G. and Acsadi, G. (1994) Emergence of early region 1 (E1)-containing replication competent adenovirus in stocks of replication defective adenovirus recombinants (ΔE1 + ΔE3) during multiple passages in 293 cells. Hum. Gene Ther. 5, 1485-1491.
33. Lochmüller, H., Petrof, B.J., Pari, G., Larochelle, N., Dodelet, V., Wang, Q., Allen, C., Prescott, S., Massie, B., Nalbantoglu, J. and Karpati, G. (1996) Short-term immunosuppression by FK 506 permits a long-term high-level dystrophin expression after adenovirus-mediated dystrophin mingene transfer to skeletal muscles of adult dystrophic (mdx) mice. Gene Ther. 3, 706-716.
34. Massie, B., Dionne, J., Lamarche, N., Fleurent, J. and Langelier, Y. (1995) Improved adenovirus vector provides herpes simplex virus ribonucleotide reductase R1 and R2 subunits very efficiently. BioTechnology 13, 602-608.
35. McGrory, J., Bautista, D. and Graham, F. (1988) A simple technique for rescue of early region 1 mutations into infectious human adenovirus type 5. Virology 177, 437-444.
36. Mittereder, N., Yei, S., Bachurski, C., Cuppoletti, J., Whitsett, J., Tolstoshev, P. and Trapnell, B. (1994) Evaluation of the efficacy and safety of in vitro adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5, 717-729.
37. Nadeau, I., Garnier, A., Côté, J., Massie, B., Chavarie, C. and Kamen, A. (1996) Improvement of recombinant protein production with the human adenovirus/293S expression system using fed-batch strategies. Biotechnol. Bioeng. 51, 613-623.
38. Quantin, B., Perricaudet, L., Tajbakhsh, S. and Mandel, L. (1992) Adenovirus as an expression vector in muscle cells in vivo. PNAS 89, 2581-2584.
39. Ragot, T., Vincent, N., Chafey, P., Vigne, E., Gilgenkrantz, H., Couton, D., Cartaud, J., Briand, P., Kaplan, J., Perricaudet, M. and Kahn, A. (1993) Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647-650.
40. Reed, K.C. and Mann, D.A. (1985) Rapid transfer of DNA from agarose gels to nylon membranes. Nucleic Acids Res. 13, 7207-7221.
41. Saiki, R.K., Gelfand, D.H., Stoffel, S., Scharf, S.J., Higuchi, R., Horn, G.T., Mullis, K.B. and Ehrlich, H.A. (1988) Primer-directed enzymatic amplification of DNA with a stable DNA-polymerase. Science 239, 487-491.
42. Schaack, J., Langer, S. and Xiaoling, G. (1995) Efficient selection of recombinant adenovirus by vectors that express β-galactosidase. J. Virol. 69, 3920-3923.
43. Southern, E.M. (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98, 503-517.
44. Stratford-Perricaudet, L.D. and Perricaudet, M. (1994) Gene therapy: the advent of adenovirus. In J.A. Wolff (Ed.), Gene Therapeutics: Methods and Applications, Birkhäuser, Boston, pp 344-362.
45. Trapnell, B.C. and Gorzilia, M. (1994) Gene therapy using adenoviral vectors. Curr. Opinion Biotechnol. 5, 617-625.
46. Van Drunen Littel-Van den Hurk, S., Parker, M.D., Massie, B., Van den Hurk, J.V., Harland, R., Babiuk, L.A. and Zamb, T.J. (1993) Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein glV. Vaccine 11, 25-35.
47. Vincent, N., Ragot T., Gilgenkrantz, H., Couton, D., Chafey, P., Gregoire, A., Briand, P., Kaplan, J., Kahn, A. and Perricaudet, M. (1993) Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet. 5, 130-134.
48. Wilmot, R.W., Amin, R.S., Perez, C.R., Wert, S.E., Keller, G., Boivin, G.P., Hirsch, R., De Incencio, J., Lu, P., Reising, S.F., Yei, S., Whitsett, J. A. and Trapnell, B.C. (1996) Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates. Hum. Gene Ther. 7, 301-318.
49. Zabner, J., Couture, L.A., Gregory, R.J., Graham, S.M., Smith, A.E. and Welsh, M.J. (1993) Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207-216.
50. Zhang, W.-W., Fang, X., Branch, C., Mazur, W., French, B. and Roth, J.A. (1993) Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. Biotechniques 15, 868-871.
51. Zhang, W.-W., Koch, P.E. and Roth, J.A. (1995) Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. Biotechniques 18, 444-447.